Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from BioNTech

Tests start for herpes vaccine

BioNTech, which helped develop one of the early COVID-19 vaccinations, is working on a herpes simplex virus vaccine

Fosun app lets China users get BioNTech COVID vaccines in Hong Kong

Fosun app lets China users get BioNTech COVID vaccines in Hong Kong

China's Shanghai Fosun Pharmaceutical Group said users of its mobile health app in China can now register to take COVID-19 booster shots in Hong Kong using BioNTech's vaccine.

First foreign COVID vaccines head to China from Germany

First foreign COVID vaccines head to China from Germany

Berlin has sent its first batch of BioNTech COVID-19 vaccines to China to be administered initially to German expatriates, a German government spokesperson said on Wednesday, the first foreign coronavirus vaccine to be delivered to the country.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Germany should help China-EU ties develop 'not subject to third party' -Xi

China and Germany should work together to foster good relations between Beijing and the European Union without any interference by a third party, President Xi Jinping told Germany's president in a phone call on Tuesday, state media reported.

The world fears a new China COVID wave, ponders how to help Xi

Officials and global health experts outside China are anxiously watching a COVID-19 surge there, worried a nation of 1.4 billion people is inadequately vaccinated and may not have the healthcare tools to treat a wave of illness expected to kill more than one million people through 2023.

What the Moderna Cancer Vaccine News Doesn't Mean

Moderna and Merck hailed preliminary results from a combination therapy as a breakthrough, but there are important nuances to consider.

China finally approves an mRNA COVID vaccine—but only for some foreigners

Beijing's uneasy relationship with mRNA vaccines is all the more relevant as it begins to relax COVID restrictions.

inkl

Read news from The Economist, FT, and more,
with one subscription

China to allow German expats to use German COVID-19 vaccines

China to allow German expats to use German COVID-19 vaccines

The Chinese foreign ministry said China and Germany had reached an agreement on providing "German vaccines" to German nationals in China, after the German Chancellor recently said that BioNTech's COVID-19 vaccine would be used by German expatriates.

Work starts on nation-first mRNA facility

Work starts on nation-first mRNA facility

Biotech giant Moderna's first mRNA vaccine facility in Australia is due to open in 2024, and will produce 100 million vaccine doses per year.

Covid: UK health regulator backs Pfizer/BioNTech vaccine for babies as young as six months

Covid: UK health regulator backs Pfizer/BioNTech vaccine for babies as young as six months

The move opens the door to vaccinating the country’s youngest children should the Joint Committee on Vaccination and Immunisation agree

Evening Standard

Fauci: China's less-effective vaccines are stopping it from exiting COVID-zero

Fauci: China's less-effective vaccines are stopping it from exiting COVID-zero

But a bigger problem for Beijing may be the number of elderly Chinese who have yet to get their booster shots.

Pfizer/BioNTech's updated COVID shot shows strong response against BQ.1.1

Pfizer/BioNTech's updated COVID shot shows strong response against BQ.1.1

Pfizer Inc and its German partner BioNTech SE said on Friday their Omicron-tailored shot produced higher virus-neutralizing antibodies in older adults against the emerging subvariant BQ.1.1 than its original vaccine.

Pfizer, BioNTech Take Next Step Toward A Pan-Covid Vaccine — But Is The Demand There?

Pfizer, BioNTech Take Next Step Toward A Pan-Covid Vaccine — But Is The Demand There?

Pfizer and BioNTech said Thursday they've started testing a next-generation Covid shot, and both vaccine stocks reversed early declines.

Investors Business Daily

Moderna Surges On New Omicron Data, Pulling Pfizer, BioNTech Along For The Ride

Moderna Surges On New Omicron Data, Pulling Pfizer, BioNTech Along For The Ride

Moderna stock popped Monday after the company said its bivalent Covid booster led to a 15-fold jump in omicron-blocking antibodies.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Weekly Must-Read: Battle Begins for China’s Private Pension Funds

Institutions are rushing to bring investment products to market in wake of government plan to grow the underdeveloped sector

European regulator recommends Pfizer's Omicron booster for children

Pfizer Inc and its partner BioNTech said on Thursday the EU health regulator has recommended authorising the use of their bivalent COVID-19 shot as a booster in children aged 5 through 11.

Investors Business Daily

Stock Market Closes Higher On Eve Of Midterm Elections; Facebook Leads Tech Stocks Higher

The stock market eked out meager gains Monday on the eve of midterm elections. Facebook shares jumped on reports of layoffs.

The Independent UK

BioNTech earnings drop but forecast for vaccine income grows

BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, has reported that third-quarter earnings are close to half what they were a year earlier

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

BioNTech Pares Losses After Doubling Profits, Raising 2022 Guidance

BioNTech doubled third-quarter profit expectations Monday and raised its full-year outlook for Covid vaccine sales — and BNTX stock jumped.

Meta Goes Twitter Way With Layoffs, Twitter Might Want Some People Back After Firing Them, Coal Miners Terminate $6B Combination Discussions: Top Stories Monday, Nov. 07

Wall Street Journal

Investors Business Daily

This Key Piece Of News Could Spark BioNTech, Moderna — And Stoke Demand For Covid Boosters

Covid vaccine stocks surged Friday after a new study suggested an added benefit of the updated omicron-targeting boosters.

Investors Business Daily

BioNTech Shares Up On Hope For Combined Flu, Covid Shot

Pfizer and BioNTech started testing a combined flu and Covid vaccine on Thursday, helping BNTX stock pare earlier Moderna-inspired losses.

Pfizer, BioNTech start COVID-flu combination vaccine study

U.S. drugmaker Pfizer Inc and its German partner BioNTech SE have started an early-stage study to evaluate a combination vaccine targeting COVID-19 and influenza, the companies said on Thursday.

The Independent UK

Pfizer starts early-stage trial of combined Covid and flu vaccine

The trial will look at the safety of the combined jab, how effective it is and whether patients suffer any side-effects

Pfizer trying a jab which protects against flu and Covid

The drug is being tested on 180 people aged 18 to 64

1 … 3 4 5 6

People

Mark Zuckerberg

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Monash University

Elliott Management

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

100,028 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play